These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3212206)

  • 1. [Long-term survival after the second and subsequent chemotherapies in 2 cases of Hodgkin's disease].
    Balwierz W; Armata J; Moryl-Bujakowska A; Pekacki A
    Przegl Lek; 1988; 45(4):412-5. PubMed ID: 3212206
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL
    Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of Hodgkin's disease after 10 years of complete remission: case report.
    Mwanda OW; Othieno-Abinya N
    East Afr Med J; 1998 Mar; 75(3):192-4. PubMed ID: 9640822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of Hodgkin's disease after failure of preliminary combined treatments].
    Balwierz W; Armata J; Strzeszyński J
    Pol Tyg Lek; 1988 Mar; 43(11):347-50. PubMed ID: 3412970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
    Sampi K; Maseki N; Sakurai M; Hattori M
    Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK; Wittekind C; Niederwieser D
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of management in Hodgkin's disease.
    Krishna A; Arya LS; Upadhyaya P
    Indian Pediatr; 1988 Aug; 25(8):744-9. PubMed ID: 3220561
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
    Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment of 62 cases of Hodgkin's disease in Côte d'Ivoire].
    Koffi KG; Sanogo I; Djigbenou D; Touré AH; Tolo A; N'Dhatz E; Kueviakoe I; Diop M; Sangaré A
    Bull Soc Pathol Exot; 2000 Feb; 93(1):55-7. PubMed ID: 10774497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cured from Hodgkin's disease].
    Brice P
    Bull Cancer; 2002; 89(7-8):666-70. PubMed ID: 12206979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy.
    Behrendt H; Brinkhuis M; Van Leeuwen EF
    Med Pediatr Oncol; 1996 Apr; 26(4):244-8. PubMed ID: 8600335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Kuleva SA
    Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
    Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term results of polychemotherapy for Hodgkin's disease in children].
    Kolygin BA
    Vopr Onkol; 2003; 49(4):501-4. PubMed ID: 14569946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
    Larraín C; Cuchacovich M; Conte G
    Rev Med Chil; 1987 Sep; 115(9):842-6. PubMed ID: 3506277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.